Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

59.08 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Is CVS Health Stock a Buy?
Via The Motley Fool
CVS Health's Options: A Look at What the Big Money is Thinking
Via Benzinga
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Key Analyst Upgrades: Why These Stocks Are Getting a Boost
Retail investors have a chance to break down the reasons behind the latest analyst upgrades and why they're being made in these three stocks. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too?
Via The Motley Fool
(CVS) - Analyzing CVS Health's Short Interest
Via Benzinga
Is CVS Health Stock an Underrated Buy?
Via The Motley Fool
CVS Health Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A 'Primetime' Year For AI
Wedbush Securities has issued an endorsement of the artificial intelligence software sector, with Managing Director Dan Ives predicting that 2025 will be a pivotal year for AI implementation across the... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
Via Benzinga
Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex'
As President-elect Donald Trump prepares to return to the White House, renowned economist Mohamed El-Erian is cautioning against media oversimplification of the incoming administration's proposed... 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Analyst Expectations For CVS Health's Future
Via Benzinga
Smart Money Is Betting Big In CVS Options
Via Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
PBMs Express Scripts, Caremark, and Optum challenge the FTC's administrative proceedings, arguing it violates constitutional rights and threatens the stability of drug pricing. 
Via Benzinga
1 Great Reason to Buy Realty Income and Hold It Forever
Via The Motley Fool
CVS Health Stock Is Moving Higher Monday: What's Going On?
CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know. 
Via Benzinga
Third Point Hedge Fund Buys Tesla, Dumps Micron
Third Point filed its Form 13F on Thursday, revealing the fund's trades from the prior quarter. 
Via Benzinga
2 Beaten-Down Dividend Stocks to Buy and Hold
They're down, but they aren't out, at least not in the eyes of patient investors. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
Looking for Passive Income? These 3 High-Yield Dividend Stocks Cut You a Check Monthly.
Dividend-paying stocks consistently outperform those that don't pay a dividend. 
Via The Motley Fool
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
The U.S. 
Via Benzinga
Dow Jumps Over 1,500 Points To A New High After Trump Win: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Trump's Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What's Driving Markets Wednesday?
An “everything rally” powered Wall Street on Wednesday after the 2024 election results, with Donald Trump emerging as the clear presidential winner. 
Via Benzinga
Topics Government
Exposures Political
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
Via Benzinga
CVS Health (CVS) Q3 2024 Earnings Call Transcript
CVS earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
S&P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%
Market surges to record highs after Trump's election, Republicans win Senate majority. Tech and small-caps up, VIX drops 22%. 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
CVS Health Stock Jumps After Mixed Q3 Earnings, Takes $1.2 Billion Restructuring Charges Hit
CVS Health posted Q3 sales of $95.43 billion, driven by gains in Health Care Benefits. The company revised leadership roles and withdrew its 2024 guidance amid financial challenges. 
Via Benzinga
CVS Reports Mixed Q3 Results: Revenue Beats Forecast, Earnings Decline
CVS Health Corporation reported a 6.3% increase in total revenues for the third quarter of 2024, reaching $95.4 billion. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.